Co-expression of BMI-1 and EZH2 polycomb-group proteins in cycling cells of T-NHL suggests that BMI-1 overexpression contributes to lymphomagenesis

被引：0
|
作者：
Raaphorst, FM
Van Kemenade, FJ
Blokzijl, T
Fieret, JH
Hamer, KM
Otte, AP
Meijer, CJLM
机构：
[1] VU Univ Hosp, Dept Pathol, Amsterdam, Netherlands
[2] Univ Amsterdam, EC Slater Inst, Amsterdam, Netherlands
来源：
JOURNAL OF PATHOLOGY | 2001年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：17A / 17A
页数：1
相关论文
共 38 条
  • [21] Expression of Bmi-1 and EZH2 in tissues adjacent to human epithelial ovarian cancer cells of orthotopic implantation in nude mice
    Genhai Zhu
    Lan Hong
    Shengtan Wang
    Zhaoxin Yang
    Chunying Chen
    Shixuan Wang
    Oncology and Translational Medicine, 2015, 1 (01) : 42 - 47
  • [22] Glioma stem cells driven by distinct BMI-1 and EZH2 transcriptional pathways targeted separately or synergistically
    Sloan, Andrew E.
    Xun, Jin
    Kim, Leo
    Wu, Quilian
    Wang, Xiuxing
    Mack, Stephen
    Miller, Tyler
    Barnholtz-Sloan, Jill
    Bao, Shideng
    Rich, Jeremy
    JOURNAL OF NEUROSURGERY, 2018, 128 (04) : 13 - 13
  • [23] DIFFERENT EXPRESSION OF EZH2 BMI-1 AND KI67 IN LOW AND HIGH GRADE NEUROENDOCRINE TUMORS OF THE LUNG
    Bondgaard, Anna-Louise R.
    Poulsen, Thomas T.
    Poulsen, Hans S.
    Skov, Birgit G.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1502 - S1502
  • [24] Expression Pattern of Polycomb Group Proteins EZH1, EZH2 and Bmi1 in Low Grade Small B-Cell Lymphomas
    Nazarullah, Alia
    Martowski, Andrew
    Alkan, Serhan
    Huang, Qin
    LABORATORY INVESTIGATION, 2015, 95 : 367A - 367A
  • [25] Expression Pattern of Polycomb Group Proteins EZH1, EZH2 and Bmi1 in Low Grade Small B-Cell Lymphomas
    Nazarullah, Alia
    Martowski, Andrew
    Alkan, Serhan
    Huang, Qin
    MODERN PATHOLOGY, 2015, 28 : 367A - 367A
  • [26] Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features
    van Leenders, Geert J. L. H.
    Dukers, Danny
    Hessels, Daphne
    van den Kieboom, Susan W. M.
    Hulsbergen, Christina A.
    Witjes, J. Alfred
    Otte, Arie P.
    Meijer, Chris J.
    Raaphorst, Frank M.
    EUROPEAN UROLOGY, 2007, 52 (02) : 455 - 463
  • [27] Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes
    Sewalt, RGAB
    van der Vlag, J
    Gunster, MJ
    Hamer, KM
    den Blaauwen, JL
    Satijn, DPE
    Hendrix, T
    van Driel, R
    Otte, AP
    MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (06) : 3586 - 3595
  • [28] Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis
    Breuer, RHJ
    Snijders, PJF
    Smit, EF
    Sutedja, TG
    Sewalt, RGAB
    Otte, AP
    van Kemenade, FJ
    Postmus, PE
    Meijer, CJLM
    Raaphorst, FM
    NEOPLASIA, 2004, 6 (06): : 736 - 743
  • [29] The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains
    Alzrigat, Mohammad
    Parraga, Alba Atienza
    Majumder, Muntasir Mamun
    Ma, Anqi
    Jin, Jian
    Osterborg, Anders
    Nahi, Hareth
    Nilsson, Kenneth
    Heckman, Caroline A.
    Oberg, Fredrik
    Kalushkova, Antonia
    Jernberg-Wiklund, Helena
    ONCOTARGET, 2017, 8 (61) : 103731 - 103743
  • [30] Distinctive expression of polycomb group proteins Bmi1 and EZH2 in non-small cell lung cancers and their clinical and clinicopathological significance
    Kikuchi, Junko
    Kinoshita, Ichiro
    Kikuchi, Eiki
    Konishi, Jun
    Shimizu, Yasushi
    Oizumi, Satoshi
    Nishimura, Masaharu
    Dosaka-Akita, Hirotoshi
    CANCER RESEARCH, 2010, 70
1234